{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:52:01Z","timestamp":1787025121504,"version":"build-2736575974"},"reference-count":36,"publisher":"Japanese Society of Allergology","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":848,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2013]]},"DOI":"10.2332\/allergolint.12-oa-0439","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T00:14:11Z","timestamp":1363306451000},"page":"45-52","source":"Crossref","is-referenced-by-count":36,"title":["Clinical Significance of Interleukin 33 (IL-33) in Patients with Eosinophilic Pneumonia"],"prefix":"10.2332","volume":"62","author":[{"given":"Naoko","family":"Mato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikatsu","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Uto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takakiyo","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Yamasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1154","reference":[{"key":"10.2332\/allergolint.12-OA-0439_bb0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2- associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.2332\/allergolint.12-OA-0439_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4781(91)90029-L","article-title":"Tetsuka T. Molecular cloning of the murine ST2 gene. Characterization and chromosomal mapping","volume":"1090","author":"Tominaga","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.2332\/allergolint.12-OA-0439_bb0015","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.4049\/jimmunol.166.11.6633","article-title":"A novel pathway regulating lipopolysaccharide-induced shock by ST2\/T1 via inhibition of Toll-like receptor 4 expression","volume":"166","author":"Sweet","year":"2001","journal-title":"J Immunol"},{"key":"10.2332\/allergolint.12-OA-0439_bb0020","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1183\/09031936.00084307","article-title":"Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury","volume":"33","author":"Mato","year":"2009","journal-title":"Eur Respir J"},{"key":"10.2332\/allergolint.12-OA-0439_bb0025","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jaci.2008.04.005","article-title":"A novel IL-1 family cytokine, IL-33, potently activates human eosinophils","volume":"121","author":"Cherry","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.2332\/allergolint.12-OA-0439_bb0030","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2008-05-157818","article-title":"Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33","volume":"113","author":"Pecaric-Petkovic","year":"2009","journal-title":"Blood"},{"key":"10.2332\/allergolint.12-OA-0439_bb0035","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/intimm\/dxn037","article-title":"Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system","volume":"20","author":"Kondo","year":"2008","journal-title":"Int Immunol"},{"key":"10.2332\/allergolint.12-OA-0439_bb0040","doi-asserted-by":"crossref","first-page":"18581","DOI":"10.1073\/pnas.1003059107","article-title":"IL-33 is a crucial amplifier of innate rather than acquired immunity","volume":"107","author":"Oboki","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2332\/allergolint.12-OA-0439_bb0045","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.4049\/jimmunol.0802387","article-title":"Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells","volume":"183","author":"Pr\u00e9fontaine","year":"2009","journal-title":"J Immunol"},{"key":"10.2332\/allergolint.12-OA-0439_bb0050","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/j.1365-2222.2008.03114.x","article-title":"Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis","volume":"38","author":"Sakashita","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.2332\/allergolint.12-OA-0439_bb0055","first-page":"419","article-title":"Role of IL-33 in bronchial asthma","volume":"48","author":"Mato","year":"2010","journal-title":"Nihon Kokyuki GakkaiZasshi"},{"key":"10.2332\/allergolint.12-OA-0439_bb0060","article-title":"Non-Neoplastic Disorders of the Lower Respiratory Tract","volume":"160\u20137","author":"Travis","year":"2001","journal-title":"Washington, DC: The American Registry of Pathology, Armed Forces Institute of Pathology"},{"key":"10.2332\/allergolint.12-OA-0439_bb0065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1056\/NEJM198908313210903","article-title":"Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure","volume":"321","author":"Allen","year":"1989","journal-title":"N Engl J Med"},{"key":"10.2332\/allergolint.12-OA-0439_bb0070","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM196904102801501","article-title":"Chronic eosinophilic pneumonia","volume":"280","author":"Carrington","year":"1969","journal-title":"N Engl J Med"},{"key":"10.2332\/allergolint.12-OA-0439_bb0075","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1378\/chest.105.5.1462","article-title":"A clinical study of idiopathic eosinophilic pneumonia","volume":"105","author":"Hayakawa","year":"1994","journal-title":"Chest"},{"key":"10.2332\/allergolint.12-OA-0439_bb0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1440-1843.2005.00648.x","article-title":"Clinico-pathological differences between acute and chronic eosinophilic pneumonia","volume":"10","author":"Mochimaru","year":"2005","journal-title":"Respirology"},{"key":"10.2332\/allergolint.12-OA-0439_bb0085","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1378\/chest.06-2596","article-title":"Circulating thymus- and activation-regulated chemokine\/CCL17 is a useful biomarker for discriminating acute eosinophilic pneumonia from other causes of acute lung injury","volume":"131","author":"Miyazaki","year":"2007","journal-title":"Chest"},{"key":"10.2332\/allergolint.12-OA-0439_bb0090","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000050532","article-title":"Yatsunami J. Increased interleukin-5 levels in bronchoalveolar lavage fluid is a major factor for eosinophil accumulation in acute eosinophilic pneumonia","volume":"68","author":"Nakahara","year":"2001","journal-title":"Respiration"},{"key":"10.2332\/allergolint.12-OA-0439_bb0095","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0091-6749(96)70206-3","article-title":"Detection of IL-5 and IL-1 receptor antagonist in bronchoalveolar lavage fluid in acute eosinophilic pneumonia","volume":"97","author":"Allen","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.2332\/allergolint.12-OA-0439_bb0100","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1164\/rccm.2112056","article-title":"Idiopathic acute eosinophilic pneumonia: a study of 22 patients","volume":"166","author":"Philit","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.2332\/allergolint.12-OA-0439_bb0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00005792-198805000-00002","article-title":"Chronic eosinophilic pneumonia. A report of 19 cases and review of the literature","volume":"67","author":"Jederlinic","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"10.2332\/allergolint.12-OA-0439_bb0110","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination","volume":"149","author":"Bernard","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.2332\/allergolint.12-OA-0439_bb0115","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1152\/jappl.1986.60.2.532","article-title":"Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution","volume":"60","author":"Rennard","year":"1986","journal-title":"J Appl Physiol"},{"key":"10.2332\/allergolint.12-OA-0439_bb0120","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jaci.2009.12.935","article-title":"Increased IL-33 expression by epithelial cells in bronchial asthma","volume":"125","author":"Pr\u00e9fontaine","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.2332\/allergolint.12-OA-0439_bb0125","doi-asserted-by":"crossref","first-page":"e3331","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS One"},{"key":"10.2332\/allergolint.12-OA-0439_bb0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.immuni.2009.06.011","article-title":"IL-33 raises alarm","volume":"31","author":"Lamkanfi","year":"2009","journal-title":"Immunity"},{"key":"10.2332\/allergolint.12-OA-0439_bb0135","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1165\/rcmb.2002-0235OC","article-title":"Cigarette smoke prevents apoptosis through inhibition of caspase activation and induces necrosis","volume":"29","author":"Julie","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.2332\/allergolint.12-OA-0439_bb0140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1465-9921-7-132","article-title":"Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cell and in a variety of transformed alveolar epithelial cells","volume":"7","author":"Kode","year":"2006","journal-title":"Respir Res"},{"key":"10.2332\/allergolint.12-OA-0439_bb0145","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0002-9440(10)64455-0","article-title":"Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome","volume":"161","author":"Albertine","year":"2002","journal-title":"Am J Pathol"},{"key":"10.2332\/allergolint.12-OA-0439_bb0150","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1164\/ajrccm.156.6.96-12081","article-title":"Neutrophil apoptosis in the acute respiratory distress syndrome","volume":"156","author":"Matute-Bello","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.2332\/allergolint.12-OA-0439_bb0155","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.4049\/jimmunol.181.7.4780","article-title":"IL-33 induces antigen-specific IL-5+ T cells and promotes allergic- induced airway inflammation independent of IL-4","volume":"181","author":"Kurowska-Stolarska","year":"2008","journal-title":"J Immunol"},{"key":"10.2332\/allergolint.12-OA-0439_bb0160","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jaci.2008.10.022","article-title":"CD34+ he- mopoietic progenitor cells are potent effectors of allergic inflammation","volume":"123","author":"Allakhverdi","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.2332\/allergolint.12-OA-0439_bb0165","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.4049\/jimmunol.1000730","article-title":"IL-33 exacerbates eosinophil-mediated airway inflammation","volume":"185","author":"Stolarski","year":"2010","journal-title":"J Immunol"},{"key":"10.2332\/allergolint.12-OA-0439_bb0170","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1378\/chest.08-0485","article-title":"Eosinophils progenitors in airway disease: clinical implications","volume":"134","author":"Denburg","year":"2008","journal-title":"Chest"},{"key":"10.2332\/allergolint.12-OA-0439_bb0175","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.1003020","article-title":"The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type response","volume":"186","author":"Kouzaki","year":"2011","journal-title":"J Immunol"},{"key":"10.2332\/allergolint.12-OA-0439_bb0180","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1073\/pnas.1115884109","article-title":"IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G","volume":"109","author":"Lefran\u00e7ais","year":"2012","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015301076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015301076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T20:39:30Z","timestamp":1562791170000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893015301076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"alternative-id":["S1323893015301076"],"URL":"https:\/\/doi.org\/10.2332\/allergolint.12-oa-0439","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}